Efficacy and safety trial of AJG533 with long term treatment in patients with chronic constipation

Trial Profile

Efficacy and safety trial of AJG533 with long term treatment in patients with chronic constipation

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Elobixibat (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Registrational
  • Sponsors Ajinomoto Pharma; Albireo AB
  • Most Recent Events

    • 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 13 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top